Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: StockDoc who wrote (14155)	7/17/2000 6:46:15 PM
From: aknahow	Read Replies (1) \| Respond to of 17367

It depends on this, do you find the definition of compelling, compelling? The results were, "compelling". The FDA felt compelled to say no to allowing a filing for a BLA without further information. Prohost, June stock letter says, "WILL THESE TWO PRODUCTS BE APPROVED?" "Our guess is that the odds are getting better than ever." They were writing about Natrecor, (Scios) and Neuprex (XOMA). Cacaito, who sends stock letters to himself and worse, bothers to read them and believe them, says, "Solamente una idiota iba pensar que Neuprex, es efectivo.!"